Which has stronger earnings and valuation, BLLN or PSNL?

Billiontoone has higher revenue and earnings than Personalis. Personalis is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Billiontoone $305.11M 15.02 $7.45M $0.55 181.16 Personalis $69.65M 14.76 -$81.27M -$1.02 N/A

Does the media favor BLLN or PSNL?

In the previous week, Billiontoone had 3 more articles in the media than Personalis. MarketBeat recorded 9 mentions for Billiontoone and 6 mentions for Personalis. Personalis' average media sentiment score of 1.28 beat Billiontoone's score of -0.55 indicating that Personalis is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Billiontoone 1 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative Personalis 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher earnings and valuation, SHC or PSNL?

Sotera Health has higher revenue and earnings than Personalis. Personalis is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Sotera Health $1.16B 3.99 $77.94M $0.41 39.67 Personalis $69.65M 14.76 -$81.27M -$1.02 N/A

Is SHC or PSNL more profitable?

Sotera Health has a net margin of 9.91% compared to Personalis' net margin of -148.11%. Sotera Health's return on equity of 39.73% beat Personalis' return on equity. Company Net Margins Return on Equity Return on Assets Sotera Health 9.91% 39.73% 7.05% Personalis -148.11% -43.52% -32.92%

Does the media prefer SHC or PSNL?

In the previous week, Personalis had 2 more articles in the media than Sotera Health. MarketBeat recorded 6 mentions for Personalis and 4 mentions for Sotera Health. Personalis' average media sentiment score of 1.28 beat Sotera Health's score of 0.91 indicating that Personalis is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sotera Health 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Personalis 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings & valuation, PSNL or CELC?

Personalis has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than Personalis, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Personalis $69.65M 14.76 -$81.27M -$1.02 N/A Celcuity N/A N/A -$177.04M -$3.90 N/A

Is PSNL or CELC more profitable?

Celcuity has a net margin of 0.00% compared to Personalis' net margin of -148.11%. Personalis' return on equity of -43.52% beat Celcuity's return on equity. Company Net Margins Return on Equity Return on Assets Personalis -148.11% -43.52% -32.92% Celcuity N/A -244.61% -50.22%

Does the media favor PSNL or CELC?

In the previous week, Personalis had 3 more articles in the media than Celcuity. MarketBeat recorded 6 mentions for Personalis and 3 mentions for Celcuity. Celcuity's average media sentiment score of 1.49 beat Personalis' score of 1.28 indicating that Celcuity is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Personalis 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Celcuity 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher valuation & earnings, PSNL or RDNT?

RadNet has higher revenue and earnings than Personalis. RadNet is trading at a lower price-to-earnings ratio than Personalis, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Personalis $69.65M 14.76 -$81.27M -$1.02 N/A RadNet $2.14B 2.16 -$18.65M -$0.18 N/A

Is PSNL or RDNT more profitable?

RadNet has a net margin of -0.66% compared to Personalis' net margin of -148.11%. RadNet's return on equity of 2.77% beat Personalis' return on equity. Company Net Margins Return on Equity Return on Assets Personalis -148.11% -43.52% -32.92% RadNet -0.66% 2.77% 0.97%

Does the media favor PSNL or RDNT?

In the previous week, RadNet had 1 more articles in the media than Personalis. MarketBeat recorded 7 mentions for RadNet and 6 mentions for Personalis. Personalis' average media sentiment score of 1.28 beat RadNet's score of 0.72 indicating that Personalis is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Personalis 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive RadNet 2 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger valuation and earnings, PSNL or VCYT?

Veracyte has higher revenue and earnings than Personalis. Personalis is trading at a lower price-to-earnings ratio than Veracyte, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Personalis $69.65M 14.76 -$81.27M -$1.02 N/A Veracyte $517.15M 7.43 $66.35M $1.09 44.18

Is PSNL or VCYT more profitable?

Veracyte has a net margin of 16.25% compared to Personalis' net margin of -148.11%. Veracyte's return on equity of 9.07% beat Personalis' return on equity. Company Net Margins Return on Equity Return on Assets Personalis -148.11% -43.52% -32.92% Veracyte 16.25% 9.07% 8.38%

Does the media refer more to PSNL or VCYT?

In the previous week, Personalis and Personalis both had 6 articles in the media. Personalis' average media sentiment score of 1.28 beat Veracyte's score of 1.14 indicating that Personalis is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Personalis 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Veracyte 3 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Personalis (PSNL) Competitors

$9.82 +0.23 (+2.39%)

As of 10:46 AM Eastern

Compare

PSNL vs. BLLN, SHC, CELC, RDNT, and VCYT

Should you buy Personalis stock or one of its competitors? MarketBeat compares Personalis with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Personalis include Billiontoone (BLLN), Sotera Health (SHC), Celcuity (CELC), RadNet (RDNT), and Veracyte (VCYT). These companies are all part of the "healthcare" industry.

How does Personalis compare to Billiontoone?

Billiontoone (NASDAQ:BLLN) and Personalis (NASDAQ:PSNL) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, analyst recommendations, risk, media sentiment, earnings and dividends.

Billiontoone currently has a consensus price target of $125.29, suggesting a potential upside of 25.74%. Personalis has a consensus price target of $11.00, suggesting a potential upside of 12.03%. Given Billiontoone's higher possible upside, equities research analysts clearly believe Billiontoone is more favorable than Personalis.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Billiontoone	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50
Personalis	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57

Billiontoone has higher revenue and earnings than Personalis. Personalis is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Billiontoone	$305.11M	15.02	$7.45M	$0.55	181.16
Personalis	$69.65M	14.76	-$81.27M	-$1.02	N/A

61.9% of Personalis shares are held by institutional investors. 4.2% of Personalis shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, Billiontoone had 3 more articles in the media than Personalis. MarketBeat recorded 9 mentions for Billiontoone and 6 mentions for Personalis. Personalis' average media sentiment score of 1.28 beat Billiontoone's score of -0.55 indicating that Personalis is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Billiontoone	1 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Negative
Personalis	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Billiontoone has a net margin of 0.00% compared to Personalis' net margin of -148.11%. Billiontoone's return on equity of 0.00% beat Personalis' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Billiontoone	N/A	N/A	N/A
Personalis	-148.11%	-43.52%	-32.92%

Summary

Billiontoone beats Personalis on 11 of the 15 factors compared between the two stocks.

How does Personalis compare to Sotera Health?

Sotera Health (NASDAQ:SHC) and Personalis (NASDAQ:PSNL) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, risk, valuation, media sentiment and analyst recommendations.

Sotera Health has a beta of 1.79, suggesting that its stock price is 79% more volatile than the broader market. Comparatively, Personalis has a beta of 2.27, suggesting that its stock price is 127% more volatile than the broader market.

In the previous week, Personalis had 2 more articles in the media than Sotera Health. MarketBeat recorded 6 mentions for Personalis and 4 mentions for Sotera Health. Personalis' average media sentiment score of 1.28 beat Sotera Health's score of 0.91 indicating that Personalis is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sotera Health	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Personalis	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Sotera Health currently has a consensus target price of $20.29, indicating a potential upside of 24.72%. Personalis has a consensus target price of $11.00, indicating a potential upside of 12.03%. Given Sotera Health's stronger consensus rating and higher probable upside, research analysts plainly believe Sotera Health is more favorable than Personalis.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sotera Health	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73
Personalis	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57

Sotera Health has a net margin of 9.91% compared to Personalis' net margin of -148.11%. Sotera Health's return on equity of 39.73% beat Personalis' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sotera Health	9.91%	39.73%	7.05%
Personalis	-148.11%	-43.52%	-32.92%

Sotera Health has higher revenue and earnings than Personalis. Personalis is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sotera Health	$1.16B	3.99	$77.94M	$0.41	39.67
Personalis	$69.65M	14.76	-$81.27M	-$1.02	N/A

91.0% of Sotera Health shares are owned by institutional investors. Comparatively, 61.9% of Personalis shares are owned by institutional investors. 15.4% of Sotera Health shares are owned by company insiders. Comparatively, 4.2% of Personalis shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Sotera Health beats Personalis on 12 of the 16 factors compared between the two stocks.

How does Personalis compare to Celcuity?

Personalis (NASDAQ:PSNL) and Celcuity (NASDAQ:CELC) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, media sentiment, analyst recommendations, dividends, profitability, risk, institutional ownership and earnings.

Personalis presently has a consensus target price of $11.00, suggesting a potential upside of 12.03%. Celcuity has a consensus target price of $152.09, suggesting a potential upside of 72.54%. Given Celcuity's stronger consensus rating and higher probable upside, analysts plainly believe Celcuity is more favorable than Personalis.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Personalis	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57
Celcuity	1 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.83

Personalis has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than Personalis, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Personalis	$69.65M	14.76	-$81.27M	-$1.02	N/A
Celcuity	N/A	N/A	-$177.04M	-$3.90	N/A

In the previous week, Personalis had 3 more articles in the media than Celcuity. MarketBeat recorded 6 mentions for Personalis and 3 mentions for Celcuity. Celcuity's average media sentiment score of 1.49 beat Personalis' score of 1.28 indicating that Celcuity is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Personalis	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Celcuity	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Personalis has a beta of 2.27, indicating that its stock price is 127% more volatile than the broader market. Comparatively, Celcuity has a beta of 0.1, indicating that its stock price is 90% less volatile than the broader market.

61.9% of Personalis shares are owned by institutional investors. Comparatively, 63.3% of Celcuity shares are owned by institutional investors. 4.2% of Personalis shares are owned by company insiders. Comparatively, 13.3% of Celcuity shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Celcuity has a net margin of 0.00% compared to Personalis' net margin of -148.11%. Personalis' return on equity of -43.52% beat Celcuity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Personalis	-148.11%	-43.52%	-32.92%
Celcuity	N/A	-244.61%	-50.22%

Summary

Personalis beats Celcuity on 8 of the 15 factors compared between the two stocks.

How does Personalis compare to RadNet?

Personalis (NASDAQ:PSNL) and RadNet (NASDAQ:RDNT) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, risk, profitability, institutional ownership, media sentiment, earnings and dividends.

RadNet has higher revenue and earnings than Personalis. RadNet is trading at a lower price-to-earnings ratio than Personalis, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Personalis	$69.65M	14.76	-$81.27M	-$1.02	N/A
RadNet	$2.14B	2.16	-$18.65M	-$0.18	N/A

In the previous week, RadNet had 1 more articles in the media than Personalis. MarketBeat recorded 7 mentions for RadNet and 6 mentions for Personalis. Personalis' average media sentiment score of 1.28 beat RadNet's score of 0.72 indicating that Personalis is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Personalis	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
RadNet	2 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

RadNet has a net margin of -0.66% compared to Personalis' net margin of -148.11%. RadNet's return on equity of 2.77% beat Personalis' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Personalis	-148.11%	-43.52%	-32.92%
RadNet	-0.66%	2.77%	0.97%

61.9% of Personalis shares are owned by institutional investors. Comparatively, 77.9% of RadNet shares are owned by institutional investors. 4.2% of Personalis shares are owned by insiders. Comparatively, 5.6% of RadNet shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Personalis currently has a consensus price target of $11.00, suggesting a potential upside of 12.03%. RadNet has a consensus price target of $87.43, suggesting a potential upside of 48.44%. Given RadNet's stronger consensus rating and higher possible upside, analysts clearly believe RadNet is more favorable than Personalis.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Personalis	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57
RadNet	1 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.90

Personalis has a beta of 2.27, indicating that its share price is 127% more volatile than the broader market. Comparatively, RadNet has a beta of 1.41, indicating that its share price is 41% more volatile than the broader market.

Summary

RadNet beats Personalis on 13 of the 17 factors compared between the two stocks.

How does Personalis compare to Veracyte?

Personalis (NASDAQ:PSNL) and Veracyte (NASDAQ:VCYT) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, earnings, profitability, risk, analyst recommendations, dividends, valuation and institutional ownership.

Veracyte has a net margin of 16.25% compared to Personalis' net margin of -148.11%. Veracyte's return on equity of 9.07% beat Personalis' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Personalis	-148.11%	-43.52%	-32.92%
Veracyte	16.25%	9.07%	8.38%

Veracyte has higher revenue and earnings than Personalis. Personalis is trading at a lower price-to-earnings ratio than Veracyte, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Personalis	$69.65M	14.76	-$81.27M	-$1.02	N/A
Veracyte	$517.15M	7.43	$66.35M	$1.09	44.18

Personalis has a beta of 2.27, indicating that its share price is 127% more volatile than the broader market. Comparatively, Veracyte has a beta of 1.98, indicating that its share price is 98% more volatile than the broader market.

Personalis currently has a consensus target price of $11.00, indicating a potential upside of 12.03%. Veracyte has a consensus target price of $47.57, indicating a potential downside of 1.22%. Given Personalis' stronger consensus rating and higher possible upside, analysts plainly believe Personalis is more favorable than Veracyte.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Personalis	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57
Veracyte	1 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.56

61.9% of Personalis shares are owned by institutional investors. 4.2% of Personalis shares are owned by insiders. Comparatively, 1.4% of Veracyte shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, Personalis and Personalis both had 6 articles in the media. Personalis' average media sentiment score of 1.28 beat Veracyte's score of 1.14 indicating that Personalis is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Personalis	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Veracyte	3 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Personalis and Veracyte tied by winning 8 of the 16 factors compared between the two stocks.

Get Personalis News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PSNL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PSNL vs. The Competition

Export

Metric	Personalis	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$1.03B	$5.85B	$6.49B	$12.31B
Dividend Yield	N/A	0.69%	2.67%	5.66%
P/E Ratio	-9.62	8.69	24.05	24.76
Price / Sales	14.76	21.69	542.61	168.32
Price / Cash	N/A	8.43	27.48	37.92
Price / Book	3.34	4.14	10.69	6.90
Net Income	-$81.27M	$99.67M	$3.57B	$337.45M
7 Day Performance	-2.20%	1.13%	1.56%	2.84%
1 Month Performance	54.39%	3.96%	2.49%	4.78%
1 Year Performance	63.38%	120.71%	26.51%	33.08%

Personalis Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PSNL Personalis	3.1746 of 5 stars	$9.82 +2.4%	$11.00 +12.0%	+59.6%	$1.03B	$69.65M	N/A	400	News Coverage Positive News Analyst Downgrade Gap Up
BLLN Billiontoone	3.6449 of 5 stars	$94.43 -2.8%	$125.29 +32.7%	N/A	$4.47B	$305.11M	171.69	620
SHC Sotera Health	3.7102 of 5 stars	$15.86 +1.5%	$20.29 +27.9%	+41.6%	$4.45B	$1.16B	38.68	3,000
CELC Celcuity	3.2526 of 5 stars	$87.43 -1.0%	$152.09 +74.0%	+631.2%	$4.31B	N/A	N/A	40	Positive News
RDNT RadNet	3.2705 of 5 stars	$54.16 -0.3%	$87.43 +61.4%	+2.3%	$4.27B	$2.14B	N/A	11,264

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:PSNL) was last updated on 6/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Personalis (PSNL) Competitors

PSNL vs. BLLN, SHC, CELC, RDNT, and VCYT

How does Personalis compare to Billiontoone?

Summary

How does Personalis compare to Sotera Health?

Summary

How does Personalis compare to Celcuity?

Summary

How does Personalis compare to RadNet?

Summary

How does Personalis compare to Veracyte?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PSNL vs. The Competition

Personalis Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Personalis (PSNL) Competitors

PSNL vs. BLLN, SHC, CELC, RDNT, and VCYT

How does Personalis compare to Billiontoone?

Do analysts prefer BLLN or PSNL?

Which has stronger earnings and valuation, BLLN or PSNL?

Do insiders & institutionals hold more shares of BLLN or PSNL?

Does the media favor BLLN or PSNL?

Is BLLN or PSNL more profitable?

Summary

How does Personalis compare to Sotera Health?

Which has more risk and volatility, SHC or PSNL?

Does the media prefer SHC or PSNL?

Do analysts recommend SHC or PSNL?

Is SHC or PSNL more profitable?

Which has higher earnings and valuation, SHC or PSNL?

Do insiders & institutionals believe in SHC or PSNL?

Summary

How does Personalis compare to Celcuity?

Do analysts rate PSNL or CELC?

Which has better earnings & valuation, PSNL or CELC?

Does the media favor PSNL or CELC?

Which has more risk and volatility, PSNL or CELC?

Do insiders and institutionals hold more shares of PSNL or CELC?

Is PSNL or CELC more profitable?

Summary

How does Personalis compare to RadNet?

Which has higher valuation & earnings, PSNL or RDNT?

Does the media favor PSNL or RDNT?

Is PSNL or RDNT more profitable?

Do institutionals & insiders hold more shares of PSNL or RDNT?

Do analysts rate PSNL or RDNT?

Which has more volatility and risk, PSNL or RDNT?

Summary

How does Personalis compare to Veracyte?

Is PSNL or VCYT more profitable?

Which has stronger valuation and earnings, PSNL or VCYT?

Which has more volatility and risk, PSNL or VCYT?

Do analysts prefer PSNL or VCYT?

Do insiders and institutionals have more ownership in PSNL or VCYT?

Does the media refer more to PSNL or VCYT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PSNL vs. The Competition

Personalis Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools